- Patent Title: Pharmaceutical composition, methods for treating and uses thereof
-
Application No.: US14918727Application Date: 2015-10-21
-
Publication No.: US09949998B2Publication Date: 2018-04-24
- Inventor: Uli Christian Broedl , Sreeraj Macha , Maximilian von Eynatten , Hans-Juergen Woerle
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Marc A. Began; Edouard G. Lebel
- Main IPC: A61K31/7034
- IPC: A61K31/7034 ; A61K31/7048 ; A61K9/20 ; A61K9/28
Abstract:
The present invention relates to certain SGLT-2 inhibitors for treating and/or preventing metabolic disorders, such as type 1 or type 2 diabetes mellitus or pre-diabetes, in patients with renal impairment or chronic kidney disease (CKD).
Public/Granted literature
- US20160038524A1 PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF Public/Granted day:2016-02-11
Information query
